1-14 of 14
Jing Ouyang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Single-Cell RNA Sequencing Reveals the Interplay between Circulating CD4 + T Cells, B Cells and Cancer-Associated Monocytes in Classic Hodgkin Lymphoma Treated with PD-1 Blockade

Julia Paczkowska, Ming Tang, Kyle T. Wright, Li Song, Kelsey Luu, Vignesh Shanmugam, Emma L. Welsh, Jason L. Weirather, Kathleen Pfaff, Robert A. Redd, Zumla Cader, Elisa Mandato, Jing Ouyang, Gali Bai, Lee N. Lawton, Philippe Armand, Scott Rodig, Xiaole Shirley Liu, Margaret A. Shipp
Journal: Blood
Blood (2023) 142 (Supplement 1): 173.
https://doi.org/10.1182/blood-2023-187038
Published: 2023
Journal Articles

MYD88 L265P augments proximal B-cell receptor signaling in large B-cell lymphomas via an interaction with DOCK8

Elisa Mandato, Qingsheng Yan, Jing Ouyang, Julia Paczkowska, Yan Qin, Yansheng Hao, Kamil Bojarczuk, Julia Hansen, Björn Chapuy, Scott J. Rodig, Sumbul Jawed Khan, Robert A. Redd, Margaret A. Shipp
Journal: Blood
Blood (2023) 142 (14): 1219–1232.
https://doi.org/10.1182/blood.2023019865
Published: 2023
Includes: Supplemental data
Journal Articles

MYD88 L265P Augments Proximal B-Cell Receptor Signaling in Large B-Cell Lymphomas Via an Interaction with DOCK8

Elisa Mandato, Qingsheng Yan, Jing Ouyang, Julia Paczkowska, Yan Qin, Yansheng Hao, Kamil Bojarczuk, Julia Hansen, Lee N. Lawton, Margaret A. Shipp
Journal: Blood
Blood (2021) 138 (Supplement 1): 1324.
https://doi.org/10.1182/blood-2021-153024
Published: 2021
Journal Articles

Pembrolizumab in Patients with Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): Data from the Keynote-013 and Keynote-170 Studies

Philippe Armand, MD PhD, Scott J Rodig, MDPhD, Vladimir Melnichenko, Catherine Thieblemont, MD, Krimo Bouabdallah, MD, Gayane Tumyan, DMSc, MD PhD, Muhit Özcan, Sergio Portino, MD, Laura Fogliatto, Dolores Caballero, MD, Jan Walewski, Zafer Gulbas, MD, Vincent Ribrag, MD, Beth A. Christian, MD, Guilherme Fleury Perini, Gilles Andre Salles, Jakub Svoboda, MD, Jasmine M. Zain, MD, Sanjay S Patel, MD MSc, MPH, Pei-Hsuan Chen, Azra H. Ligon, PhD, Jing Ouyang, Donna S Neuberg, ScD, Robert A. Redd, MS, Arkendu Chatterjee, Robert J Orlowski, MD, Arun Balakumaran, MD PhD SM, Margaret A. Shipp, MD, Pier Luigi Zinzani, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 228.
https://doi.org/10.1182/blood-2018-99-110220
Published: 2018
Journal Articles

Mass cytometry of Hodgkin lymphoma reveals a CD4 + regulatory T-cell–rich and exhausted T-effector microenvironment

Fathima Zumla Cader, Ron C. J. Schackmann, Xihao Hu, Kirsty Wienand, Robert Redd, Bjoern Chapuy, Jing Ouyang, Nicole Paul, Evisa Gjini, Mikel Lipschitz, Philippe Armand, David Wu, Jonathan R. Fromm, Donna Neuberg, X. Shirley Liu, Scott J. Rodig, Margaret A. Shipp
Journal: Blood
Blood (2018) 132 (8): 825–836.
https://doi.org/10.1182/blood-2018-04-843714
Published: 2018
Includes: Multimedia, Supplemental data
Journal Articles

Expression of Major Histocompatibility Complex (MHC) Class II, but Not MHC Class I, Predicts Outcome in Patients with Classical Hodgkin Lymphoma (cHL) Treated with Nivolumab (Programmed Death-1 [PD-1] Blockade)

Margaretha G.M. Roemer, MSc, Robert A. Redd, MS, Fathima Zumla Cader, MD PhD MRCP, Christine J. Pak, Sara Abdelrahman, Jing Ouyang, Stephanie Sasse, MD, Anas Younes, MD, Michelle A. Fanale, MD, Armando Santoro, MD, Pier Luigi Zinzani, MD, John M Timmerman, MD, Graham Collins, MD PhD, Rod Ramchandren, MD, Jonathon B Cohen, MDMS, Jan Paul De Boer, MD PhD, John Kuruvilla, MD, Kerry J Savage, BSc, MD MSc, Marek Trneny, MD, Stephen M Ansell, MD PhD, Mariana Sacchi, Benedetto Farsaci, MD, Anne Sumbul, Philippe Armand, MD PhD, Donna S. Neuberg, ScD, Geraldine S. Pinkus, Azra H. Ligon, Scott J. Rodig, MDPhD, Margaret A. Shipp, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1450.
https://doi.org/10.1182/blood.V130.Suppl_1.1450.1450
Published: 2017
Journal Articles

Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease

Bjoern Chapuy, Hongwei Cheng, Akira Watahiki, Matthew D. Ducar, Yuxiang Tan, Linfeng Chen, Margaretha G. M. Roemer, Jing Ouyang, Amanda L. Christie, Liye Zhang, Daniel Gusenleitner, Ryan P. Abo, Pedro Farinha, Frederike von Bonin, Aaron R. Thorner, Heather H. Sun, Randy D. Gascoyne, Geraldine S. Pinkus, Paul van Hummelen, Gerald G. Wulf, Jon C. Aster, David M. Weinstock, Stefano Monti, Scott J. Rodig, Yuzhuo Wang, Margaret A. Shipp
Journal: Blood
Blood (2016) 127 (18): 2203–2213.
https://doi.org/10.1182/blood-2015-09-672352
Published: 2016
Includes: Supplemental data
Journal Articles

CXCR4 Upregulation Is a Biomarker Of Sensitivity To Targeted Inhibition Of B-Cell Receptor Signaling In Diffuse Large B-Cell Lymphoma

Linfeng Chen, PhD, Yansheng Hao, MD, PhD, Jing Ouyang, PhD, Bjoern Chapuy, MD, PhD, Donna S. Neuberg, ScD, Thomas M Habermann, MD, Przemyslaw Juszczynski, MD, PhD, Scott J Rodig, MD, PhD, Stefano Monti, PhD, Margaret A Shipp, MD
Journal: Blood
Blood (2013) 122 (21): 631.
https://doi.org/10.1182/blood.V122.21.631.631
Published: 2013
Journal Articles

Galectin-1 serum levels reflect tumor burden and adverse clinical features in classical Hodgkin lymphoma

Brief Report
Jing Ouyang, Annette Plütschow, Elke Pogge von Strandmann, Katrin S. Reiners, Sabine Ponader, Gabriel A. Rabinovich, Donna Neuberg, Andreas Engert, Margaret A. Shipp
Journal: Blood
Blood (2013) 121 (17): 3431–3433.
https://doi.org/10.1182/blood-2012-12-474569
Published: 2013
Journal Articles

Galectin-1 Serum Levels Reflect Tumor Burden and Adverse Clinical Features in Hodgkin Lymphoma

Jing Ouyang, PhD, Annette Plütschow, PhD, Elke Pogge, PhD, Sabine Ponader, PhD, Gabriel Rabinovich, PhD, Donna S. Neuberg, ScD, Andreas Engert, MD, Margaret A. Shipp, MD
Journal: Blood
Blood (2012) 120 (21): 51.
https://doi.org/10.1182/blood.V120.21.51.51
Published: 2012
Journal Articles

Viral induction and targeted inhibition of galectin-1 in EBV + posttransplant lymphoproliferative disorders

Jing Ouyang, Przemyslaw Juszczynski, Scott J. Rodig, Michael R. Green, Evan O'Donnell, Treeve Currie, Myriam Armant, Kunihiko Takeyama, Stefano Monti, Gabriel A. Rabinovich, Jerome Ritz, Jeffery L. Kutok, Margaret A. Shipp
Journal: Blood
Blood (2011) 117 (16): 4315–4322.
https://doi.org/10.1182/blood-2010-11-320481
Published: 2011
Includes: Supplemental data
Journal Articles

Expression and Targeted Inhibition of the Immunoregulatory Carbohydrate-Binding Lectin, Galectin 1, in EBV-Driven Post-Transplant Lymphoproliferative Disorders.

Jing Ouyang, PhD, Przemyslaw Juszczynski, MD, PhD, Evan O'Donnell, Myriam Armant, PhD, Scott J. Rodig, MD, PhD, Kunihiko Takeyama, MD, PhD, Stefano Monti, PhD, Gabriel Rabinovich, PhD, Jeffery Lorne Kutok, MD, PhD, Jerome Ritz, MD, Margaret A. Shipp, MD
Journal: Blood
Blood (2009) 114 (22): 96.
https://doi.org/10.1182/blood.V114.22.96.96
Published: 2009
Journal Articles

Selective Expression of the Immunoregulatory Lectin, Galectin-1, in Precursor B Cell Acute Lymphoblastic Leukemias (ALLs) with MLL Rearrangements

Przemyslaw Juszczynski, MD, PhD, Scott J. Rodig, MD, PhD, Kunihiko Takeyama, MD, PhD, Jing Ouyang, PhD, Jorg Faber, MD, PhD, Scott Armstrong, MD, PhD, Jeffery L. Kutok, MD, PhD, Margaret A. Shipp, MD
Journal: Blood
Blood (2008) 112 (11): 2539.
https://doi.org/10.1182/blood.V112.11.2539.2539
Published: 2008
Journal Articles

Hodgkin’s Lymphoma Reed Sternberg Cells over Express the T-Cell Inhibitory Carbohydrate-Binding Lectin, Galectin 1: Role of AP-1 and Likely Mechanism of Tumor Immune Escape.

Przemyslaw Juszczynski, MD, PhD, Jing Ouyang, PhD, Jeffery L. Kutok, MD, PhD, Stefano Monti, PhD, Wen Chen, MD, Paola Dal Cin, PhD, Jeremy S. Abramson, MD, Kunihiko Takeyama, MD, PhD, Todd R. Golub, MD, Jon C. Aster, MD, PhD, Gabriel A. Rabinovich, PhD, Margaret A. Shipp, MD
Journal: Blood
Blood (2006) 108 (11): 469.
https://doi.org/10.1182/blood.V108.11.469.469
Published: 2006